Upregulation of KLF4 by methylseleninic acid in human esophageal squamous cell carcinoma cells: Modification of histone H3 acetylation through HAT/HDAC interplay

Esophageal squamous cell carcinoma (ESCC) occurs at a very high frequency in certain areas of China. Supplementation with selenium‐containing compounds was associated with a significantly lower cancer mortality rate in a study conducted in Linxia, China. Thus, selenium could be a potential anti‐esophageal cancer agent. In this study, methylseleninic acid (MSA) could inhibit cell growth of ESCC cells in vitro and in vivo. Upon treated with MSA, the activity of histone deacetylases (HDACs) was decreased and general control nonrepressed protein 5 (GCN5) was upregulated in ESCC cells. Meanwhile, a significant increase of H3K9 acetylation (H3K9ac) was detected. Upregulation of Krüppel‐like factor 4 (KLF4) was also observed after MSA treatment. Additionally, the acetylated histone H3 located more at KLF4 promoter region after MSA treatment, shown by chromatin immunoprecipitation (ChIP) assay. Moreover, knockdown of GCN5 decreased the protein level of both H3K9ac and KLF4, along with less cell growth inhibition. Taken all, our results indicated that MSA could inhibit ESCC cell growth, at least in part, by MSA‐HDAC/GCN5‐H3K9ac‐KLF4 axis. To our best knowledge, this is the first report that MSA induced acetylation of histone H3 at Lys9, which might depend on the activities and the balance between HDACs and HATs. © 2014 Wiley Periodicals, Inc.

[1]  H. Harris,et al.  Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease. , 2013, Chemical Society reviews.

[2]  Yan Liu,et al.  Akt kinase targets the association of CBP with histone H3 to regulate the acetylation of lysine K18 , 2013, FEBS letters.

[3]  S. Amin,et al.  Post SELECT: selenium on trial. , 2013, Future medicinal chemistry.

[4]  N. Minato,et al.  E2A and CBP/p300 Act in Synergy To Promote Chromatin Accessibility of the Immunoglobulin κ Locus , 2012, The Journal of Immunology.

[5]  L. Mishra,et al.  Disruption of Klf4 in villin-positive gastric progenitor cells promotes formation and progression of tumors of the antrum in mice. , 2012, Gastroenterology.

[6]  M. Jeong,et al.  Trichostatin A prevents neointimal hyperplasia via activation of Krüppel like factor 4. , 2011, Vascular pharmacology.

[7]  David E. Williams,et al.  Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells , 2011, Clinical Epigenetics.

[8]  L. Chodosh,et al.  Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. , 2011, Neoplasia.

[9]  C. Hiley,et al.  Methylseleninic acid inhibits HDAC activity in diffuse large B-cell lymphoma cell lines , 2011, Cancer Chemotherapy and Pharmacology.

[10]  Li-Rong Yu,et al.  Distinct roles of GCN5/PCAF‐mediated H3K9ac and CBP/p300‐mediated H3K18/27ac in nuclear receptor transactivation , 2011, The EMBO journal.

[11]  R. Place,et al.  Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. , 2010, Cancer research.

[12]  Fang Yu,et al.  Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion , 2010, Oncogene.

[13]  Wei Zhang,et al.  beta-Catenin/TCF pathway plays a vital role in selenium induced-growth inhibition and apoptosis in esophageal squamous cell carcinoma (ESCC) cells. , 2010, Cancer letters.

[14]  Jialiang Liang,et al.  A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. , 2010, Cell stem cell.

[15]  J. Wrana,et al.  Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. , 2010, Cell stem cell.

[16]  F. Fitzpatrick,et al.  Redox Signaling, Alkylation (Carbonylation) of Conserved Cysteines Inactivates Class I Histone Deacetylases 1, 2, and 3 and Antagonizes Their Transcriptional Repressor Function* , 2010, The Journal of Biological Chemistry.

[17]  H. Kee,et al.  Krüppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy. , 2009, Journal of molecular and cellular cardiology.

[18]  A. Ganesan,et al.  Epigenetic therapy: histone acetylation, DNA methylation and anti-cancer drug discovery. , 2009, Current cancer drug targets.

[19]  Li Wang,et al.  Putative Tumor-Suppressive Function of Krüppel-Like Factor 4 in Primary Lung Carcinoma , 2009, Clinical Cancer Research.

[20]  Huawei Zeng,et al.  Methylselenol, a selenium metabolite, induces cell cycle arrest in G1 phase and apoptosis via the extracellular-regulated kinase 1/2 pathway and other cancer signaling genes. , 2009, The Journal of nutrition.

[21]  J. Yanagisawa,et al.  KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERα , 2009, Oncogene.

[22]  William H. Bisson,et al.  Alpha-keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells. , 2009, Carcinogenesis.

[23]  William H. Bisson,et al.  α-Keto Acid Metabolites of Naturally Occurring Organoselenium Compounds as Inhibitors of Histone Deacetylase in Human Prostate Cancer Cells , 2009, Cancer Prevention Research.

[24]  Hongbo Hu,et al.  Methyl-Selenium Compounds Inhibit Prostate Carcinogenesis in the Transgenic Adenocarcinoma of Mouse Prostate Model with Survival Benefit , 2009, Cancer Prevention Research.

[25]  J. Crowley,et al.  Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). , 2009, JAMA.

[26]  R. Zhao,et al.  Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells. , 2008, Carcinogenesis.

[27]  Michael Grunstein,et al.  Adenovirus Small e1a Alters Global Patterns of Histone Modification , 2008, Science.

[28]  Michael Q. Zhang,et al.  Combinatorial patterns of histone acetylations and methylations in the human genome , 2008, Nature Genetics.

[29]  G. Combs,et al.  Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite. , 2008, Carcinogenesis.

[30]  Y. Dong,et al.  Krüppel-Like Factor 4 Is a Novel Mediator of Selenium in Growth Inhibition , 2008, Molecular Cancer Research.

[31]  M. Grunstein,et al.  Functions of site-specific histone acetylation and deacetylation. , 2007, Annual review of biochemistry.

[32]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[33]  Zuo-Feng Zhang,et al.  Dietary selenium intake, aldehyde dehydrogenase‐2 and X‐ray repair cross‐complementing 1 genetic polymorphisms, and the risk of esophageal squamous cell carcinoma , 2006, Cancer.

[34]  R. Bernards,et al.  The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene , 2005, Nature Cell Biology.

[35]  E. Korn,et al.  Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib. , 2005, Gastroenterology.

[36]  Tsung-Teh Wu,et al.  Drastic down-regulation of Krüppel-like factor 4 expression is critical in human gastric cancer development and progression. , 2005, Cancer research.

[37]  Zhihua Liu,et al.  Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by β‐catenin /TCF pathway in human esophageal squamous cell carcinoma , 2005, International journal of cancer.

[38]  M. Matsuoka,et al.  Identification of Aberrantly Methylated Genes in Association with Adult T-Cell Leukemia , 2004, Cancer Research.

[39]  C. Peterson,et al.  Histones and histone modifications , 2004, Current Biology.

[40]  W. Willett,et al.  A prospective study of plasma selenium levels and prostate cancer risk. , 2004, Journal of the National Cancer Institute.

[41]  Z. Y. Chen,et al.  Krüppel-like factor 4 is transactivated by butyrate in colon cancer cells. , 2004, The Journal of nutrition.

[42]  J. Davie.  Inhibition of histone deacetylase activity by butyrate. , 2003, The Journal of nutrition.

[43]  M. Torbenson,et al.  Overexpression of Krüppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity , 2003, Oncogene.

[44]  P. Marks,et al.  Histone deacetylases and cancer: causes and therapies , 2001, Nature Reviews Cancer.

[45]  E W Gunter,et al.  Prospective study of serum selenium levels and incident esophageal and gastric cancers. , 2000, Journal of the National Cancer Institute.

[46]  Z. Y. Chen,et al.  Role of gut-enriched Krüppel-like factor in colonic cell growth and differentiation. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[47]  H. Ganther,et al.  In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. , 2000, Cancer research.

[48]  M. Grunstein.  Histone acetylation in chromatin structure and transcription , 1997, Nature.

[49]  C. Allis,et al.  Transcription-linked acetylation by Gcn5p of histones H3 and H4 at specific lysines , 1996, Nature.

[50]  C. Allis,et al.  Tetrahymena Histone Acetyltransferase A: A Homolog to Yeast Gcn5p Linking Histone Acetylation to Gene Activation , 1996, Cell.

[51]  D. St Johnston,et al.  Supplementary Figure 5 , 2009 .

[52]  Sung-Hoon Kim,et al.  Methylseleninic acid inhibits microvascular endothelial G1 cell cycle progression and decreases tumor microvessel density , 2008, International journal of cancer.

[53]  C. Allis,et al.  Signaling to chromatin through histone modifications: how clear is the signal? , 1998, Cold Spring Harbor symposia on quantitative biology.